SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-075519
Filing Date
2021-03-10
Accepted
2021-03-10 07:30:55
Documents
13
Period of Report
2021-03-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d155025d8k.htm   iXBRL 8-K 25875
2 EX-99.1 d155025dex991.htm EX-99.1 11454
  Complete submission text file 0001193125-21-075519.txt   167862

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acet-20210310.xsd EX-101.SCH 3072
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acet-20210310_lab.xml EX-101.LAB 18887
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acet-20210310_pre.xml EX-101.PRE 11861
6 EXTRACTED XBRL INSTANCE DOCUMENT d155025d8k_htm.xml XML 3468
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 21728257
SIC: 2834 Pharmaceutical Preparations